Applied Therapeutics, Inc. SEC Filings

Filed On	Filing
17 Feb 2026	SCHEDULE 13G/A
13 Feb 2026	15-12G
06 Feb 2026	EFFECT
06 Feb 2026	EFFECT
04 Feb 2026	Form 4: Kanter Stacy J., Director Returned 22,500 shares to the issuer · Disposed of 42,500 shares (Tender Offer) · Disposed of 263,690 Stock Option (Right to Buy) (Disposition to Issuer)
03 Feb 2026	Form 4: Hooks Corwin Dale, Chief Commercial Officer Received 312,500 shares as a grant or award · Returned 862,500 shares to the issuer · Disposed of 5,753 shares (Tender Offer)
03 Feb 2026	Form 4: Chinoporos Constantine, See Remarks Received 437,500 shares as a grant or award · Returned 1,000,000 shares to the issuer · Disposed of 57,111 shares (Tender Offer)
03 Feb 2026	Form 4: Skyler Jay S, Director Returned 22,500 shares to the issuer · Disposed of 42,500 shares (Tender Offer) · Disposed of 263,690 Stock Option (Right to Buy) (Disposition to Issuer)
03 Feb 2026	Form 4: Funtleyder Leslie D., Director Received 1,187,500 shares as a grant or award · Returned 2,375,000 shares to the issuer · Disposed of 152,959 shares (Tender Offer) · 1 more
03 Feb 2026	Form 4: Bailey Evan Prescott, Chief Medical Officer Received 437,500 shares as a grant or award · Returned 1,235,915 shares to the issuer · Disposed of 60,901 shares (Tender Offer) · 1 more
03 Feb 2026	Form 4: Lerner Teena, Director Returned 22,500 shares to the issuer · Disposed of 82,922 shares (Tender Offer) · Disposed of 287,631 Stock Option (Right to Buy) (Disposition to Issuer)
03 Feb 2026	POS AM
03 Feb 2026	POS AM
03 Feb 2026	S-8 POS
03 Feb 2026	S-8 POS
03 Feb 2026	S-8 POS
03 Feb 2026	S-8 POS
03 Feb 2026	25-NSE
03 Feb 2026	SC 14D9/A
03 Feb 2026	SC TO-T/A

Comments